Hiroe Tada

455 total citations
26 papers, 315 citations indexed

About

Hiroe Tada is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Hiroe Tada has authored 26 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Hiroe Tada's work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Cells and Metastasis (9 papers) and CAR-T cell therapy research (4 papers). Hiroe Tada is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cancer Cells and Metastasis (9 papers) and CAR-T cell therapy research (4 papers). Hiroe Tada collaborates with scholars based in Japan and United States. Hiroe Tada's co-authors include Hideyuki Takahashi, Kazuaki Chikamatsu, Shota Ida, Reika Kawabata‐Iwakawa, Masato Shino, Koichi Sakakura, Kyoichi Kaira, Hiroki Ishii, Tetsunari Oyama and Shigeki Takeda and has published in prestigious journals such as Scientific Reports, Cancer Science and Journal of Materials Science Materials in Medicine.

In The Last Decade

Hiroe Tada

23 papers receiving 315 citations

Peers

Hiroe Tada
Max Partridge United Kingdom
Anna Maria Wirsing Norway
Kailiu Wu China
Е. Л. Чойнзонов Russia
Rachel A. Woolaver United States
Yoshitaka Michifuri Japan
Sanjib Dey India
Marice Alcantara United States
Gan Xiong China
Miki Katsurano Japan
Max Partridge United Kingdom
Hiroe Tada
Citations per year, relative to Hiroe Tada Hiroe Tada (= 1×) peers Max Partridge

Countries citing papers authored by Hiroe Tada

Since Specialization
Citations

This map shows the geographic impact of Hiroe Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroe Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroe Tada more than expected).

Fields of papers citing papers by Hiroe Tada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroe Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroe Tada. The network helps show where Hiroe Tada may publish in the future.

Co-authorship network of co-authors of Hiroe Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroe Tada. A scholar is included among the top collaborators of Hiroe Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroe Tada. Hiroe Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shino, Masato, et al.. (2025). Comparison of physician and large language model chatbot responses to online ear, nose, and throat inquiries. Scientific Reports. 15(1). 21346–21346.
2.
Chikamatsu, Kazuaki, et al.. (2025). Circulating Tumor Cells in Head and Neck Squamous-Cell Carcinoma Exhibit Distinct Properties Based on Targeted Epithelial-Related Markers. Current Issues in Molecular Biology. 47(4). 240–240. 1 indexed citations
3.
4.
Takahashi, Hideyuki, et al.. (2024). Tumor antigen‑specific interleukin‑10‑producing T‑cell response in patients with head and neck squamous cell carcinoma. Oncology Letters. 28(4). 456–456. 1 indexed citations
5.
Tada, Hiroe, Reika Kawabata‐Iwakawa, Hideyuki Takahashi, & Kazuaki Chikamatsu. (2024). Novel Index Based on Inflammatory Markers Correlates with Treatment Efficacy of Nivolumab for Recurrent/Metastatic Head and Neck Cancer. Oncology. 103(8). 714–724. 2 indexed citations
6.
7.
Takahashi, Hideyuki, Reika Kawabata‐Iwakawa, Shota Ida, et al.. (2022). Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma. Oral Oncology. 136. 106270–106270. 28 indexed citations
8.
Takahashi, Hideyuki, et al.. (2022). Circulating T Cell Subsets and ILC2s are Altered in Patients With Chronic Rhinosinusitis With Nasal Polyps After Dupilumab Treatment. American Journal of Rhinology and Allergy. 37(1). 58–64. 13 indexed citations
9.
Tada, Hiroe, Hideyuki Takahashi, Kanae Yamada, et al.. (2021). Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab. Cancer Immunology Immunotherapy. 71(4). 851–863. 9 indexed citations
10.
Yamada, Kanae, Shota Ida, Hiroe Tada, et al.. (2021). In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms. Journal of Materials Science Materials in Medicine. 32(6). 58–58. 5 indexed citations
11.
12.
Tada, Hiroe, et al.. (2021). The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma. Anticancer Research. 41(2). 885–893. 4 indexed citations
13.
Takahashi, Hideyuki, et al.. (2021). Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma. Scientific Reports. 11(1). 17789–17789. 29 indexed citations
14.
Tada, Hiroe, et al.. (2021). Systemic immune responses are associated with molecular characteristics of circulating tumor cells in head and neck squamous cell carcinoma. Molecular and Clinical Oncology. 15(1). 147–147. 3 indexed citations
15.
Takahashi, Hideyuki, et al.. (2021). Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Scientific Reports. 11(1). 16134–16134. 36 indexed citations
16.
Tada, Hiroe, Hideyuki Takahashi, Reika Kawabata‐Iwakawa, et al.. (2020). Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma. Scientific Reports. 10(1). 21573–21573. 16 indexed citations
17.
18.
Tada, Hiroe, et al.. (2020). Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma. Oral Oncology. 102. 104558–104558. 27 indexed citations
19.
Takahashi, Hideyuki, Koichi Sakakura, Yukiko Arisaka, et al.. (2019). Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma. Anticancer Research. 39(6). 3039–3046. 26 indexed citations
20.
Chikamatsu, Kazuaki, Hiroe Tada, Hideyuki Takahashi, et al.. (2018). Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma. Oral Oncology. 89. 34–39. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Max Partridge Breakdown of academic impact, for papers by Anna Maria Wirsing Breakdown of academic impact, for papers by Kailiu Wu Breakdown of academic impact, for papers by Е. Л. Чойнзонов Breakdown of academic impact, for papers by Rachel A. Woolaver Breakdown of academic impact, for papers by Yoshitaka Michifuri Breakdown of academic impact, for papers by Sanjib Dey Breakdown of academic impact, for papers by Marice Alcantara Breakdown of academic impact, for papers by Gan Xiong Breakdown of academic impact, for papers by Miki Katsurano
Rankless by CCL
2026